In Vivo Imaging Market is Expected to Show a Sound Growth During the forecast period 2023-2032

Pune, India, Sept, 2022/MRFR Press Release/- Market Research Future has a half cooked research report on the global in vivo imaging market.

Market Highlights:

The In Vivo Imaging Market is expected to reach USD 4.3 billion by 2032 at 5.20% CAGR during the forecast period 2023-2032

The prevalence of diseases such as cancer involves diagnosis of … to know how the cancerous cell are evolving inside the host. This factor is used to provide effective treatment to the cancer patients. This is facilitated by the in vivo imaging techniques. Moreover, in preclinical studies it is often required to test the drug on animal models to know the mechanism of drug binding to its target and vice versa, which has increased the in vivo imaging R&D over the last few years. This facilitates the growth of the market.

A report was published by the National Cancer Institute in 2016, which states that the number of new cancer cases were about 1.6 million in 2016, followed by an increase in the national expenditure for cancer, which was about USD 125 billion in 2010 and is expected to reach USD 156 billion by 2020. This will increase the demand for the diagnosis of cancer, which will boost the market. 

Increasing prevalence of cancer, rising R&D in imaging, and increasing healthcare expenditures will drive the growth of the global market over the review period. However, lack of awareness among people as well as skilled physician and high cost of the diagnostics method will restrain the market growth during the assessment period. 

Global In vivo Imaging Market Players

Some of the key players profiled in the report are Bruker, MILabs B.V., FUJIFILM VisualSonics Inc., Mediso Ltd., LI-COR, Inc., Aspect Imaging., TRIFOIL IMAGING, MR Solutions, Biospace Lab S.A., and New England Biolabs.

Regional Analysis

The Americas holds the largest market share and will continue to lead the marker during the given period due to high healthcare expenditures, the presence of global players, and high acceptance of new technologies within the region.

Europe is the second largest market owing to the presence of effective healthcare structure and well-developed economies. 

Asia Pacific region is expected to grow rapidly. China and India are likely to lead this market due to the fastest growing healthcare sector during the forecast period.

The Middle East & Africa have the least market share. Additionally, factors such as lack of awareness, low healthcare expenditures will restrain the market during the corresponding period.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global In vivo Imaging Market” Research Report – Forecast till 2032.

Segmentation

The global in vivo imaging market has been segmented on the basis of applications, techniques, and end users.

Based on the application, the market has been segmented as nuclear imaging, optical imaging, and others.

Based on the techniques, the market has been segmented as radioisotopes based, biomarkers based, luminescent proteins based technique, and others.

Based on the end users, the market has been segmented as hospitals & clinics, imaging centers, research organizations, and others.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of In Vivo Imaging Market Research Report